A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
Clinical trial NCT02029430 · COMPLETED
Trial details
- NCT number
- NCT02029430
- Sponsor
- ImmunityBio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-03
- Primary completion
- 2016-04-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.